Navigation Links
Is a gluten-free diet enough to control the complications of celiac disease?
Date:9/3/2014

New Rochelle, NY, September 2, 2014A lifelong gluten-free diet (GFD) is the conventional approach to managing celiac disease, a chronic inflammatory disorder affecting the small intestine that can result in malnutrition. However, recent evidence shows that a GFD may not be sufficient to prevent serious complications related to celiac disease. A detailed discussion of the metabolic disorders and functional abnormalities that can develop, and nutritional treatments for these is presented in a Review article published in Journal of Medicinal Food, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the Journal of Medicinal Food website until October 2, 2014.

Sara Farnetti and coauthors, Catholic University of the Sacred Heart (Rome, Italy), cover a broad scope of digestive and nutrient absorptive processes in individuals with celiac disease that may be compromised due to increased inflammation. In the article "Functional and Metabolic Disorders in Celiac Disease: New Implications for Nutritional Treatment", the authors discuss how diminished gallbladder and pancreatic function, and increased gut permeability may contribute to the development of overweight and obesity, and impaired glucose and lipid metabolism and insulin secretion in these patients.

"This article reviews the extensive literature on lifelong gluten-free diet supplementation to celiac disease patients and makes outstanding recommendations," says Journal of Medicinal Food Editor-in-Chief Sampath Parthasarathy, MBA, PhD, Florida Hospital Chair in Cardiovascular Sciences, University of Central Florida, Orlando. "The authors conclude that plant oils and products are able to stimulate the gall bladder to promote the absorption process and provide better nutrition to these patients. The conclusion that a lifelong gluten-free diet provision must be accompanied by proper nutrient supplementation is a sound one; however, caution must be exercised in using fried oil as a gall bladder stimulant."

About the Journal

Journal of Medicinal Food is an authoritative, peer-reviewed, multidisciplinary journal published monthly in print and online. Led by Editors-in-Chief Sampath Parthasarathy, MBA, PhD, and Young-Eun Lee, PhD, Wonkwang University, Jeonbuk, Korea, this scientific journal publishes original research on the bioactive substances of functional and medicinal foods, nutraceuticals, herbal substances, and other natural products. The Journal explores the chemistry and biochemistry of these substances, as well as the methods for their extraction and analysis, the use of biomarkers and other methods to assay their biological roles, and the development of bioactive substances for commercial use. Tables of content and a sample issue may be viewed on the Journal of Medicinal Food website.

About the Publisher

Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including The Journal of Alternative and Complementary Medicine. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.

Contact: Kathryn Ryan, Mary Ann Liebert, Inc., (914) 740-2100, kryan@liebertpub.com

Mary Ann Liebert, Inc. 140 Huguenot St., New Rochelle, NY 10801-5215 Phone: (914) 740-2100 (800) M-LIEBERT Fax: (914) 740-2101 http://www.liebertpub.com


'/>"/>
Contact: Kathryn Ryan
kryan@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert  

Related biology news :

1. Gluten-free diet relieves brain fog in patients with Celiac disease
2. Gluten-free diet reduces risk of type 1 diabetes in mice
3. Gluten-free crackers made with hemp flour and decaffeinated green tea leaves
4. New technologies and ingredients provide better options for gluten-free eating
5. New canary seed is ideal for gluten-free diets in celiac disease
6. Pasta made from green banana flour a tasty alternative for gluten-free diets
7. A battery small enough to be injected, energetic enough to track salmon
8. Sometimes the average just isnt good enough
9. Are enough women included in medical device studies, as required by the FDA?
10. Where water is limited, researchers determine how much water is enough
11. 3 hands on nutrition classes -- Enough to impact health behaviors in lower income women
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Is a gluten-free diet enough to control the complications of celiac disease?
(Date:2/21/2017)... February 21, 2017 Der weltweite ... wachsen. Nach einem Gespräch mit mehr als 50 Vertretern aus ... zu überwinden gilt, um diese Prognose zu realisieren. ... ... Mobilisierung der finanziellen Mittel für die Biobank, die Implementierung ...
(Date:2/10/2017)... , Feb 10, 2017 Research ... report "Personalized Medicine - Scientific and Commercial Aspects" ... ... medicine. Diagnosis is integrated with therapy for selection of treatment ... early detection and prevention of disease in modern medicine. Biochip/microarray ...
(Date:2/8/2017)... Feb. 7, 2017 The biometrics market ... the confluence of organizations, desires to better authenticate ... systems (password and challenge questions), biometrics is quickly ... systems. The market is driven by use cases, ... consumer and enterprise uses cases, with consumer-facing use ...
Breaking Biology News(10 mins):
(Date:2/22/2017)... ... February 22, 2017 , ... LabRoots , the leading ... around the world, is pleased to announce the launch of a new scholarship for ... (STEM) fields. , This merit-based scholarship is open to all high school seniors, 17 ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... that Dr. Daniel Spyker, PhD, MD former Acting Deputy Director in the FDA ... Pilot Drug Evaluation Staff has joined the company as an Expert Consultant. , ...
(Date:2/21/2017)... -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a late-stage ... and restore the health of patients, intends to report operational highlights ... Thursday, March 2, 2017, and to host a conference call the ... call is as follows: U.S. (toll free): 1-888-347-5280 ... ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... research and development (R&D), today announced the establishment of Genedata Limited as a ... Kevin Teburi, a recognized expert in life science informatics. Creating the UK subsidiary ...
Breaking Biology Technology: